Literature DB >> 11266352

Myth, menace or medical blessing? The clinical potential and the problems of genetic vaccines.

W W Leitner1.   

Abstract

Mesh：

Substances：

Year:  2001        PMID： 11266352      PMCID： PMC1083850          DOI： 10.1093/embo-reports/kve054

Source DB:  PubMed          Journal:  EMBO Rep        ISSN： 1469-221X            Impact factor:   8.807


× No keyword cloud information.
  6 in total

1.  Infectious diseases. Polio outbreak raises questions about vaccine.

Authors:  L Greensfelder
Journal:  Science       Date:  2000-12-08       Impact factor: 47.728

2.  A phase I study using direct combination DNA injections for the immunotherapy of metastatic melanoma. University of Colorado Cancer Center Clinical Trial.

Authors:  P Walsh; R Gonzalez; S Dow; R Elmslie; T Potter; L M Glode; A E Baron; C Balmer; K Easterday; J Allen; P Rosse
Journal:  Hum Gene Ther       Date:  2000-06-10       Impact factor: 5.695

3.  Aluminum compounds as vaccine adjuvants.

Authors: 
Journal:  Adv Drug Deliv Rev       Date:  1998-07-06       Impact factor: 15.470

Review 4.  The role of CpG dinucleotides in DNA vaccines.

Authors:  A M Krieg; A K Yi; J Schorr; H L Davis
Journal:  Trends Microbiol       Date:  1998-01       Impact factor: 17.079

Review 5.  DNA and RNA-based vaccines: principles, progress and prospects.

Authors:  W W Leitner; H Ying; N P Restifo
Journal:  Vaccine       Date:  1999-12-10       Impact factor: 3.641

6.  Direct gene transfer into mouse muscle in vivo.

Authors:  J A Wolff; R W Malone; P Williams; W Chong; G Acsadi; A Jani; P L Felgner
Journal:  Science       Date:  1990-03-23       Impact factor: 47.728
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.